Shineco unit achieves mass production of high-purity soybean phospholipids

Shineco (SISI) announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. This breakthrough was made possible through its proprietary APCC-UF pure physical extraction technology, overcoming a persistent global technical challenge in the field. Testing by multiple authoritative institutions confirms that the product’s key metrics meet internationally leading standards, providing robust technical support for the global upgrade of the natural active phospholipid industry. Analysts suggest that Shineco’s technological breakthrough possesses significant scarcity value and commercial potential, likely to transform the company’s business structure and enhance its overall gross margin and valuation. Investors are advised to monitor closely the progress of capacity rollout, downstream customer partnerships, and international market access.